News
Biontech and Pfizer to produce COVID-19 vaccine by the end of the year

190 Reads

Continue Reading
Published
7 months agoon
Both Biontech and Pfizer say 100 million of these vaccines will be available by the end of 2020.
The US government has announced $ 2 billion for the purchase of 100 million covid-19 vaccines, which are currently being jointly developed by Biontech and Pfizer.
A statement from the two companies said the United States would receive 100 million doses of the vaccine in the first phase, and the country would purchase another 500 million more in the future.
BionTech in Germany and Pfizer in the United States have launched a study to develop a vaccine against covid-19 in recent months, pledging to make the drug available to the rest of the world. .
The two companies say 100 million of these vaccines will be produced by the end of 2020, while at least 1.3 billion more vaccines will be produced by the end of 2021.
Earlier this month, Pfizer and Biontech announced the preliminary results of a trial of 45 vaccines, confirming the quality of the vaccine, and plans for a second phase. in Brazil and Argentina soon.
Amaka Odinakachi, a born writer. She started writing at 12, when she won the best writer in High School. Since then she stated to chase her dreams.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.